University of Michigan Comprehensive Cancer Center

Entity type image
Type: Organization
Name: University of Michigan Comprehensive Cancer Center
First reported May 16 2013 - Updated May 16 2013 - 1 reports

Primary care physicians vital to complete care of prostate cancer patients

NCI Cancer Center News Androgen deprivation therapy is a common and effective treatment for advanced prostate cancer. However, among other side-effects, it can cause significant bone thinning in men on long-term treatment. A new study from the University ... [Published National Cancer Institute - May 16 2013]
First reported May 14 2013 - Updated May 15 2013 - 1 reports

Angelina's Mastectomy: Oncologists Respond

Earn Free CME Credits by reading the latest medical news in your specialty.Sign UpWhen Angelina Jolie charted her course of action against the breast cancer cards she'd been dealt, she didn't seek direction from an academic medical center.Instead, she ... [Published MedPage Today - May 14 2013]
First reported Apr 21 2013 - Updated Apr 21 2013 - 1 reports

ANN ARBOR: Free event highlights latest in breast cancer care, research

University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, April 20, at Washtenaw Community Coll ... [Published Heritage Newspapers - Apr 21 2013]
First reported Apr 20 2013 - Updated Apr 20 2013 - 1 reports

ANN ARBOR: U-M offers free throat cancer screenings Saturday

ANN ARBOR – Throat cancer can take away your voice, your jaw and your ability to swallow food, but it also can be treated if caught early enough.In an effort to do just that, the University of Michigan Comprehensive Cancer Center and the U-M Department ... [Published Heritage Newspapers - Apr 20 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

1 in 4 Women Skips Breast Cancer Therapy

Breast cancer survivors not all taking adjuvant endocrine therapy(dailyRx News) The majority of breast cancers are fed by the hormones estrogen and progesterone. That’s why women with hormone-sensitive breast cancer are prescribed medicines to block these ... [Published Daily Rx - Apr 17 2013]
First reported Dec 10 2012 - Updated Dec 10 2012 - 1 reports

Targeted therapy shows efficacy in advanced PCa

An orally bioavailable tyrosine kinase inhibitor demonstrated dramatic and rapid effects on advanced prostate cancer, according to researchers from the University of Michigan Comprehensive Cancer Center, Ann Arbor. Original Article ... [Published BioPortfolio - Dec 10 2012]
First reported Dec 10 2012 - Updated Dec 10 2012 - 1 reports

Vorinostat reduces risk of graftvs.host disease from bone marrow transplant treatments

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive Cancer Center. Original ... [Published BioPortfolio - Dec 10 2012]
First reported Dec 05 2012 - Updated Dec 05 2012 - 1 reports

Cabozantinib effectively treats prostate cancer spread to bones

A new drug demonstrated dramatic and rapid effects on prostate cancer that had spread to the bone, according to a study reported by University of Michigan Comprehensive Cancer Center researchers. Original Article ... [Published BioPortfolio - Dec 05 2012]
First reported Nov 28 2012 - Updated Nov 28 2012 - 1 reports

Most women who have double mastectomy don't need it study finds

About 70 percent of women who have both breasts removed following a breast cancer diagnosis do so despite a very low risk of facing cancer in the healthy breast, new research from the University of Michigan Comprehensive Cancer Center finds. Original ... [Published BioPortfolio - Nov 28 2012]

Quotes

"These results on Dr. Raimondo's carefully collected samples are really exciting and have clear practice-changing implications" says co-author David Ahlquist, M D , who led the collaborating laboratory team at Mayo Clinic in Rochester...
-Abstract TPS5095: "A phase I study of cabozantinib plus docetaxel and prednisone in metastatic castrate resistant prostate cancer." [This is an NCI-CTEP study.]

More Content

All (32) | News (30) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
For Prostate Cancer, Continuous Treatment Beats... [Published Bottom Line Publications - 23 hours ago]
More women remove breasts to avoid cancer [Published Atlanta Voice - May 24 2013]
Mayo Clinic: Molecular marker from pancreatic '... [Published Brightsurf Science News - May 20 2013]
Exelixis to Present at American Society of Clin... [Published Individual.com - May 20 2013]
Exelixis' Cabozantinib to be Featured at 2013 A... [Published Individual.com - May 20 2013]
A Guide To Not Saying Dumb Things About Angelin... [Published Popular Science - May 16 2013]
A Guide To Not Saying Dumb Things About Angelin... [Published Popular Science - New Technology, Science News, ... - May 16 2013]
Primary care physicians vital to complete care ... [Published National Cancer Institute - May 16 2013]
Reminder: Cabozantinib to be Featured in Nine P... [Published Business Wire - May 15 2013]
Most Women who have Double Mastectomy Don’t Nee... [Published Health Impact News - May 15 2013]
Angelina's Mastectomy: Oncologists Respond [Published MedPage Today - May 14 2013]
Why double mastectomies are up [Published CNN - May 14 2013]
Time to tumor growth helps predict survival ben... [Published Brightsurf Science News - May 10 2013]
Paradigm Announces Scientific Advisory Board [Published WebWire - May 07 2013]
Cabozantinib to be Featured in Nine Presentatio... [Published Zecco - May 07 2013]
For CML Patients, Many Factors Surround Questio... [Published Oncology Times - May 04 2013]
ANN ARBOR: Free event highlights latest in brea... [Published Heritage Newspapers - Apr 21 2013]
ANN ARBOR: U-M study says 25 percent don’t comp... [Published Heritage Newspapers - Apr 21 2013]
ANN ARBOR: U-M offers free throat cancer screen... [Published Heritage Newspapers - Apr 20 2013]
25 percent don't complete recommended breast ca... [Published NewsRX - Apr 20 2013]
Sarcoma Alliance Examines Failure of Promising ... [Published Zecco - Apr 18 2013]
New Guidelines from NCCN for Chordoma & Giant C... [Published Oncology Times - Apr 18 2013]
SHOP TALK: Appointments, Promotions, Honors, Gr... [Published Oncology Times - Apr 18 2013]
1 in 4 Women Skips Breast Cancer Therapy [Published Daily Rx - Apr 17 2013]
University of Colorado Cancer Center Elected to... [Published PRWeb - Mar 20 2013]
John Greene, Senior Director of Customer Centri... [Published CisionWire - English - Mar 06 2013]
Targeted therapy shows efficacy in advanced PCa [Published BioPortfolio - Dec 10 2012]
Vorinostat reduces risk of graftvs.host disease... [Published BioPortfolio - Dec 10 2012]
Cabozantinib effectively treats prostate cancer... [Published BioPortfolio - Dec 05 2012]
Most women who have double mastectomy don't nee... [Published BioPortfolio - Nov 28 2012]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
Reminder: Cabozantinib to be Featured in Nine P... [Published Business Wire - May 15 2013]
John Greene, Senior Director of Customer Centri... [Published CisionWire - English - Mar 06 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.